Peri-operative management of the surgical patient with diabetes GL059
|
|
- Cornelius Parrish
- 6 years ago
- Views:
Transcription
1 DT Peri-operative management of the surgical patient with diabetes GL059 Approval Approval Group Job Title, Chair of Committee Date Anaesthetics Clinical Governance Chair Anaesthetic governance Nov 2016 Change History Version Date Author, job title Reason 7 Apr 2016 J Rechner, A Pal 7.1 Nov 2016 J Rechner, A Pal Consultant Anaesthetist, Endocrine Consultant Consultant Anaesthetist, Endocrine Consultant Update and review Review, no changes Job Title: Consultant Anaesthetist, Endocrine Consultant Review Date: Nov 2018 Location: Corporate governance shared drive GL059
2 Contents 1. Purpose 2. Introduction 3. Scope 4. Referring primary care physician 5. Surgical department 6. Pre-operative assessment 7. Management of existing therapy 8. Intra-operative care and monitoring 9. Fluid management 10. Variable rate intravenous insulin infusion 11. Returning to pre-operative medication and diet 12. Patients with diabetes requiring emergency surgery 1. Purpose The purpose of this clinical guideline is to describe the peri-operative management of the surgical patient with diabetes. 2. Introduction The Joint British Diabetes Societies produced guidance in 2011 relating to the management of adults with diabetes undergoing surgery and elective procedures. This was revised in September 2015 with considerably greater focus given to maintaining good glucose control in the perioperative period as there is now good data to show that poor glucose control peri-operatively is associated with an increased risk of all the complication of surgery as well as an increased length of hospital stay. The Association of Anaesthetists of Great Britain and Ireland subsequently published guidance in September 2015 which mirrors the JBDS guidance. Diabetes affects 10-15% of the surgical population, and, as the number of people with diabetes continues to rise (by up to 50% in the next decade), so too will the number of patients requiring surgery with diabetes continue to rise. Perioperative mortality rates are up to 50% greater than in the non-diabetic population with a two to three fold increase in complications such as respiratory infections, surgical site infections, myocardial infarction and acute kidney injury. In order to reduce perioperative complications it is important that diabetes be as well controlled as possible before elective surgery, with a HbA1c of <69 mmol/mol for elective cases. 2
3 3. Scope This clinical guideline applies to all health professionals involved in the management of the surgical patient with diabetes. This includes the referring primary care physician and health professionals in the secondary care setting involved in perioperative management of surgical patients. 4. Referring Primary Care Physician Glycaemic control should be checked at the time of referral for surgery. Information about duration, type of diabetes, current treatment and complications should be made available to the secondary care team. If the HbA1c is greater than 69mmol/mol, every effort should be made to improve control. For frail elderly patients, or patients with multiple co-morbidities at risk of hypoglycaemia, a higher upper limit of 75 mmol/mol may be appropriate. For patients currently under a secondary care team, the referring primary care physician should communicate directly with this team for advice. For patients managed in the community, the referring primary care physician can refer/communicate with: a community endocrinology consultant, community diabetic specialist nurse or secondary care physician, if required. This information should be included in the referral for surgery. 5. Surgical Department. Referrals to surgical departments for elective surgery may not be accepted if the above criteria are not met. 6. Pre-operative assessment Patients with diabetes attending pre-operative assessment clinics should have their Hba1c checked if not done so within the previous month. Patients with diabetes should be provided with verbal and written information about diabetes in the peri-operative period. If the HbA1c is >69 mmol/mol, and a specialist opinion, as defined above, has not been sought, elective surgery should be delayed while control is improved. Surgical procedures which are 3
4 urgent (or involve additional risks if delayed) should not be postponed without further discussion with the surgeon. For frail elderly patients, or patients with multiple comorbidities, at risk of hypoglycaemia, a higher upper limit of 75 mmol/mol may be appropriate. All patients with a HbA1c >69mmol/mol should receive written information advising them of the increased risks of surgery and providing advice on improving diabetic control. Patients who are being discharged back to their GP should receive written information asking them to attend their GP. A referral to a diabetes specialist, as defined above, may be warranted. The patient should be advised to attend their GP surgery at three months for a repeat HbA1c (fructosamine is also acceptable). If the HbA1c at three months is less than 69mmol/mol (fructosamine less 345 µmol ), the GP or patient can contact the operating surgeon and be listed for surgery. If the HbA1c remains high, the GP should make an active decision with the patient that all possible avenues for improvement have been explored and should communicate this, along with any interventions/referrals, to the anaesthetic department. As different surgical procedures carry different risks, the decision to proceed with poorly controlled diabetes will lie with the surgeon and anaesthetist. Patients undergoing procedures, for whom delaying surgery may incur other complications (such as laparascopic cholecystectomies), with a HbA1c greater than 69mmol/mol, will require the anaesthetist to communicate with the operating surgeon in order to agree an acceptable time frame for optimisation. If time allows, an internal referral to the diabetes team is indicated. Please fax a referral to CAT 9 on Patients undergoing urgent surgery, with a HbA1c greater than 69mmol/mol, should be referred internally to the diabetes team by fax to CAT 9 on 7678 or discussed with the on call diabetes registrar on bleep 199/192. The patient may need to be admitted the night before for a variable rate intravenous insulin infusion (VRIII) if on the morning list, or first thing in the morning if on an afternoon list. In a small number of cases, following discussion with a diabetes specialist, it may not be possible to improve diabetic control. In these circumstances the patient should be made aware of the increased risks. These patients may need to be admitted earlier than normal in case they require a variable rate intravenous insulin infusion (VRIII). Pre-operative tests to assess co-morbidities should be ordered in line with NICE guidance. Random blood glucose is no longer indicated. Patients should be first on the operating list to minimise the period of fasting. 4
5 Patients should be provided with written instructions about management of their diabetes medication on the day of surgery and management of hypo- or hyperglycaemia in the perioperative period. Patients should be advised to carry a form of glucose in case of symptoms of hypoglycaemia; this should be a clear fluid or suitable alternative. 7. Management of existing therapy Patients should be allowed to retain control and possession of, and continue to self-administer, their medication. Patients on continuous subcutaneous insulin pumps (CSII) are very well educated and will be able to self-manage their diabetes appropriately if given the opportunity to do so. If the starvation period is short, pump therapy should be continued and patients should remain on their basal rate until they are eating and normally. If more than one meal is missed, the pump should be removed and a VRIII used. Significant hyperkalaemia may occur after discontinuation of an insulin pump. CBG and electrolytes should be checked and hypoglycaemia treated in the normal way. Insulin-Short starvation time-no more than one missed meal 5
6 Insulin Once daily (Lantus, Levemir, Tresiba, Insulatard, Humulin I, Insuman) Twice daily Biphasic or ultra-long acting (Novomix 30, Humulin M3, Humalog Mix 25, Humalog Mix 50, Insuman Comb 25, Insuman Comb 50, Levemir, Lantus) Day before admission Reduce dose by 20% No dose change AM list Day of surgery PM list On VRIII Reduce dose by 20% Reduce dose by 20% Halve the usual morning dose. Leave evening dose unchanged Stop until eating and Short-acting (animal neutral, novorapid, Humulin S Apidra) and Intermediate-acting (animal isophane, insulatard, Humulin I, Insuman) No dose change Calculate total morning dose of insulin; give half as intermediate-acting only. Evening dose unchanged Stop until eating and Three to five injections daily No dose change Basal bolus regime: Omit morning and lunchtime short-acting insulins; keep basal unchanged Premixed AM insulin: Halve morning dose and omit lunch time dose Give usual morning insulin. Omit lunch time dose Stop until eating and Oral hypoglycaemic agents-short starvation time-no more than one missed meal 6
7 Agent Day before admission Day of surgery AM list PM list On VRIII Drugs that require omission when fasting owing to risk of hypoglycaemia Meglitinides (repaglinide, nateglinide) Sulphonylureas (glibenclamide, gliclazide, glipizide) Take as normal Omit AM dose Give AM dose if eating Stop until eating and Take as normal Omit AM dose Stop until eating and Drugs that require omission when fasting owing to risk of ketoacidosis SGLT-2 inhibitors (dapagliflozin, canagliflozin) Take as normal Drugs that may be continued when fasting Halve the morning dose; normal evening dose Stop until eating and Acarbose Take as normal Take as normal Stop until eating and DPP-IV inhibitors (sitagliptin, vildagliptin, saxagliptin, alogliptin, linagliptin) GLP-1 analogues (exenatide, liraglutide, lixisenatide) Take as normal Take as normal Stop until eating and Take as normal Take as normal Take as normal Pioglitazone Take as normal Take as normal Stop until eating and Metformin* Take as normal Take as normal Stop until eating and *Metformin. Omit on morning of procedure and for the following 48 hrs if contrast medium is to be used or the egfr is less than 60 ml/min.1.73/m 2 8. Intra-operative care and monitoring The aim of intra-operative care is to maintain good glycaemic control and normal electrolyte concentrations. An intra-operative CBG range of 6 10 mmol/l should be aimed for (an upper limit of 12 mmol/l may be tolerated at times). The CBG should be checked before induction of anaesthesia and monitored regularly during the 7
8 procedure (at least hourly, or more frequently if the results are outside the target range). The CBG, insulin infusion rate and substrate infusion should be recorded on the anaesthetic record. Management of intra-operative hyperglycaemia and hypoglycaemia If the CBG exceeds 12 mmol/l and insulin has been omitted, capillary blood ketone levels should be measured. If the capillary blood ketones are > 3 mmol/l or there is significant ketonuria (> 2+ on urine sticks) the patient should be treated as having diabetic ketoacidosis (DKA). Diabetic ketoacidosis is a medical emergency and specialist help should be obtained from the diabetes team. Please contact the diabetes registrar on bleep 199/192. If DKA is not present, the high blood glucose should be corrected using subcutaneous insulin or by altering the rate of the VRIII (if in use). If two subcutaneous insulin doses do not work, a VRIII should be started. Insulin doses should be written in full, avoiding abbreviations of the words units. 1) Treatment of hyperglycaemia in a patient with Type-1 diabetes Subcutaneous rapid-acting insulin (such as Novorapid) should be given (up to a maximum of 6 units), assuming that 1 unit will drop the CBG by 3 mmol/l. If the patient is awake, it is important to ensure that the patient is content with proposed dose (patients may react differently to subcutaneous rapid-acting insulin). The CBG should be checked hourly and a second dose considered only after 2 hrs. 2) Treatment of hyperglycaemia in a patient with Type-2 diabetes (including those on insulin) Subcutaneous rapid-acting insulin (such as Novorapid) 0.1 unit/kgshould be given (up to a maximum of 6 units). The CBG should be checked hourly and a second dose considered only after 2 h. A VRIII should be considered if the patient remains hyperglycaemic. 3) Treatment of intra-operative hypoglycaemia For a CBG mmol/l, 50 ml of glucose 20% (10 g) should be given intravenously; for hypoglycaemia < 4.0 mmol/la dose of 100 ml of glucose 20% (20 g) should be given. 9. Fluid management 8
9 It is now recognised that Plasmalyte solution is safe to administer to patients. The initial fluid management for patients requiring a VRIII should be glucose 5% in saline 0.45% pre-mixed with either potassium chloride 0.15% (20 mmol/l) or potassium chloride 0.3% (40 mmol/l), depending on the presence of hypokalaemia (< 3.5 mmol/l). Currently only the former is available in 500ml bags in this Trust. Fluid should be administered at the rate that is appropriate for the patient s usual maintenance requirements usually ml/kg/day (approximately 83 ml/h for a 70-kg patient). Electrolytes should be checked daily in patients on a VRIII 10. Variable rate intravenous insulin infusion A VRIII should be avoided if possible but is the preferred option in: patients who will miss more than one meal; patients with Type 1 diabetes who have not received background insulin; patients with poorly controlled diabetes and most patients with diabetes requiring emergency surgery. Please refer to the Guideline for safe administration of the VRIII for adult in-patients with diabetes (CG242). 50 units of Actrapid is mixed with 50ml 0.9% sodium chloride and administered intravenously though an extension set with a Y connector for simultaneous administration of glucose 5% in saline 0.45% with potassium chloride 0.15%. There should be an anti-syphon valve on the insulin line and an anti-reflux valve on the dextrose saline line. Rate of VRIII: Blood glucose mmol/l Regimen A Units/hr Regimen B Units/hr 0-4 Stop and treat hypo Stop and treat hypo Over If CBG remains above 10mmol/L for 4 hours move to regimen B. For patients already on insulin treatment in excess of 100 units in 24hrs start on regimen B. If CBG remains above 10mmol/L for 4 hours on regimen B please contact the Diabetes Specialist team on bleep 199 or 192. Out of hours, it is reasonable for a suitably experienced doctor to either increase the units of insulin per hour or decrease the rate of infusion of glucose 5% in saline 0.45% with potassium chloride 0.15%. Unopposed intravenous infusion of insulin on the ward is not recommended. 9
10 11. Returning to pre-operative medication and diet The postoperative blood glucose management plan, and any alterations to existing medications, should be clearly communicated to ward staff. If the patient has type-1 diabetes and a VRIII has been used, it must be continued for min after the patient has had their subcutaneous insulin. Premature discontinuation is associated with iatrogenic DKA. Oral hypoglycaemic agents should be recommenced at pre-operative doses once the patient is ready to eat and drink; withholding or reduction in sulphonylureas may be required if the food intake is likely to be reduced. Metformin should only be restarted if the estimated glomerular filtration rate exceeds 50 ml/min.1.73 m 2. Restarting subcutaneous insulin for patients already established on insulin should commence once the patient is able to eat and drink without nausea or vomiting. The pre-surgical regimen should be restarted, but may require adjustment because the insulin requirement may change as a result of postoperative stress, infection or altered food intake. The diabetes specialist team should be consulted if the blood glucose levels are outside the acceptable range (6 12 mmol/l) or if a change in diabetes management is required. The transition from intravenous to subcutaneous insulin should take place when the next mealrelated subcutaneous insulin dose is due, for example with breakfast or lunch. There should be an overlap between the end of the VRIII and the first injection of subcutaneous insulin, which should be given with a meal and the intravenous insulin and fluids discontinued min later. If the patient was previously on a long-acting insulin analogue such as Lantus, Levemir or Tresbia, this should have been continued and thus the only action should be to restart his/her usual rapidacting insulin at the next meal as outlined above. If the basal insulin was stopped, the insulin infusion should be continued until a background insulin has been given. For the patient on a twice-daily, fixed-mix regimen, the insulin should be re-introduced before breakfast or before the evening meal, and not at any other time. The VRIII should be maintained for min after the subcutaneous insulin has been given. For the patient on a continuous subcutaneous insulin infusion, the subcutaneous insulin infusion should be recommenced at the patient s normal basal rate; the VRIII should be continued until the 10
11 next meal bolus has been given. The subcutaneous insulin infusions should not be re-started at bedtime. 12. Patients with diabetes requiring emergency surgery A VRIII should be the default technique to manage a patient undergoing emergency surgery because of the unpredictability of the starvation period. Use of a fixed-rate intravenous insulin infusion. This should only be used if the patient requires immediate surgery and has concurrent DKA. Early involvement of the diabetes inpatient specialist team should be sought. The aim is for the patient to be taken to the operating theatre with a CBG of 6 10 mmol/l (6 12 mmol/l may be acceptable), without overt DKA, and having been adequately resuscitated. The CBG should be checked regularly (hourly as a minimum whilst acutely unwell),and a VRIII established using dextrose 5% in saline 0.45% with pre-mixed potassium chloride as the substrate. The patient should be checked for ketonaemia (> 3.0 mmol.l1) or significant ketonuria (> 2+ on urine sticks) if the CBG exceeds 12 mmol.l If possible, long-acting insulin (Levemir, Lantus, Tresiba) should be continued in all patients at 80% of the usual dose. 13. References 1. Association of Anaesthetists of Great Britain and Ireland Guideline: Peri-operative management of the surgical patient with diabetes September JBDS Guideline: Management of adults with diabetes undergoing surgery and elective procedures: Improving standards September Perioperative iv fluids in diabetic patients- don t forget the salt- Simpson, Levy, Hall Anaesthesia 2008, Day Surgery and the diabetic patient, - British Association of Day Surgery
Fasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period
Fasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period Dr Ketan Dhatariya MBBS MSc MD MS FRCP Consultant in Diabetes and Endocrinology Norfolk and Norwich
More informationTitle Peri-operative Guidelines for the Management of Patients with Diabetes. Author s job title Diabetes Specialist Nurse Department.
Patients with Document Control Title Peri-operative Guidelines for the Management of Patients with Author Directorate Medicine Version Date Issued 0.1 Jan 2011 Status Draft Initial version Author s job
More informationPERIOPERATIVE DIABETES GUIDELINE
PERIOPERATIVE DIABETES GUIDELINE This Guideline does not replace the need for the application of clinical judgment in respect to each individual patient. Background Diabetes mellitus is estimated to affect
More informationUpdated August /08/2020
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Guideline for the management of adults with diabetes
More informationManagement of Adults with Diabetes Undergoing Surgery and Elective Procedures Guidelines. Diabetes Inpatient Steering Group June 2016
Management of Adults with Diabetes Undergoing Surgery and Elective Procedures Guidelines Diabetes Inpatient Steering Group June 2016 1. Introduction 1.1 The aim of the guideline is to improve standards
More informationInformation for Patients
Information for Patients Guidance for Diabetic Persons having an OGD or Bronchoscopy This guidance is provided to assist with your preparation for your endoscopic procedure. If you feel unclear about how
More informationClinical Guidelines. Management of adult patients with diabetes undergoing endoscopic procedures
Clinical Guidelines Management of adult patients with diabetes undergoing endoscopic s Document Detail Document type Clinical Guideline Management of adult Patients with diabetes Undergoing Document name
More informationManaging Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines
Document Control Title Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Author Author s job title Specialist Nurse Consultant Physician Department Directorate Unscheduled Care Version Date
More informationPeri-Operative Guidelines for Management of Diabetes Patients
Peri-Operative Guidelines for Management of Diabetes Patients Target blood glucose 6-10 mmol/l for all patients Acceptable blood glucose 4-11 mmol/l for all patients Definitions Non-Insulin Glucose Lowering
More informationManagement of adults with diabetes undergoing surgery and elective procedures: improving standards
Surgical outpatients Hospital admission Theatre and recovery Discharge Primary care referral Pre-operative assessment Post-operative care Management of adults with diabetes undergoing surgery and elective
More informationGuideline for the perioperative management of diabetes for Adult patients undergoing surgery
Guideline for the perioperative management of diabetes for Adult patients undergoing surgery This guidance does not override the individual responsibility of health professionals to make appropriate decision
More informationThe principles of insulin adjustment guidance
The principles of insulin adjustment guidance Tips for insulin titration Blood glucose (BG) monitoring is needed to help identify the efficacy of treatment in diabetes. Monitor blood glucose according
More informationGuideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation
CHILDREN S SERVICES Guideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation Background Surgery places stress on the body and will alter glucose control and insulin
More informationGuidelines for the care of Children with Diabetes Mellitus undergoing Surgery
Guidelines for the care of Children with Diabetes Mellitus undergoing Surgery Background Surgery places physical and emotional stress on the body. This, alongside new surroundings, parental anxiety and
More informationHow they work and when to take them. Diabetes Medications
How they work and when to take them Diabetes Medications BIGUANIDES Metformin Actions Slows down the release of glucose from the liver. Helps the bodies cells become more sensitive to insulin. Pros Weight
More informationStaff at the Nottingham Children s Hospital. Guidelines process.
Diabetes and Surgery Title of Guideline Contact Name and Job Title (author) Guideline for the management of children and young people with diabetes aged 18 or under requiring surgery Dr Priyha Santhanam,
More informationManagement of adults with diabetes undergoing surgery and elective procedures: Improving standards Summary
Management of adults with diabetes undergoing surgery and elective procedures: Improving standards Summary Revised March 2016 Lead authorship Dr Ketan Dhatariya Consultant in Diabetes, Norfolk and Norwich
More informationManagement of adults with diabetes undergoing surgery and elective procedures: Improving standards
Management of adults with diabetes undergoing surgery and elective procedures: Improving standards Revised September 2015 Changes in the second edition of the peri-operative document Preoperative pathway
More informationPre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013
Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013 www.diabetesvic.org.au Plan/ overview Issue/ presenting problems
More informationDept of Diabetes Main Desk
Dept of Diabetes Main Desk 01202 448060 Glucose management in Type 2 Diabetes in Adults The natural history of type 2 diabetes is for HbA1c to deteriorate with time. A stepwise approach to treatment is
More informationInpatient Diabetes 20/01/2015. What should I do? Hyperglycaemia why does it matter? Why are the BSLs unstable? BSL parameters
Hyperglycaemia why does it matter? Inpatient Diabetes Angela Sheu Endocrine Registrar St George Hospital Hyperglycaemia at admission is a predictor of mortality May be part of stress response (eg post
More informationSt Helens & Knowsley Teaching Hospitals Adult Inpatient Diabetes Management Guidelines v24
St Helens & Knowsley Hospitals, 2014-16 Adult Inpatient Diabetes Management Guidelines St Helens & Knowsley Teaching Hospitals Adult Inpatient Diabetes Management Guidelines 2014-2016 v24 Title Adult Inpatient
More informationTREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse
TREATMENTS FOR TYPE 2 DIABETES Susan Henry Diabetes Specialist Nurse How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management
More informationDiabetes, Type 2 Management
CLINICAL GUIDELINE Diabetes, Type 2 Management A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised on the applicability
More informationThere have been important changes in diabetes care which may not be covered in undergraduate textbooks.
Diabetes Clinical update There have been important changes in diabetes care which may not be covered in undergraduate textbooks. Changes in the diagnosis of diabetes a) HbA1C Since 2011, World Health Organisation
More informationMellitus undergoing Surgery
Clinical Guideline Care of children Children and young under people with 18 diabetes years mellitus with Diabetes Mellitus undergoing Surgery SETTING FOR STAFF PATIENTS Insert hospital name Medical and
More informationEast of England Paediatric Diabetes Network
East of England Paediatric Diabetes Network Management of Children and Adolescents with Diabetes Requiring Surgery and Other Procedures Early & Effective Communication Surgeon/physician communicates with
More informationEast of England Children & Young People s (CYP) Diabetes Network
East of England Children & Young People s (CYP) Diabetes Network Management of Children and Young people with Diabetes (Age >6months-18th birthday) Requiring Surgery and Other Procedures Communication
More informationInjectable Therapies in Diabetes
Injectable Therapies in Diabetes Diabetes Specialist Nurse Linda Burns Learning Outcomes Understand the place of injectible therapies in diabetes Understand when patients may require insulin therapy Consider
More informationTYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE
TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE DEFINITION Type 1 Diabetes: described as a total lack of insulin produced by the pancreas for the requirements of the tissues. If left untreated,
More informationGlucose Control drug treatments
Glucose Control drug treatments It should be noted that glitazones are under suspicion of precipitating acute cardiac events and current recommendations contraindicate the use of glitazones in patients
More informationLynda Astbury Lead Diabetes Specialist Nurse
Lynda Astbury Lead Diabetes Specialist Nurse WARNING SIGNS AND SYMPTOMS Is patient Feeling unwell? Blood glucose level above 13mmol/L Or higher than the patients day to day readings (even if not eating)
More informationHow can we improve outcomes in Type 2 diabetes?
How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management Identify and treat all risk factors Use rational pharmacological therapy
More informationDIABETES INDICATIONS FOR INSULIN
DIABETES INDICATIONS FOR INSULIN 1 Introduce the likely need for insulin in the future early on as part of patient education Emphasise that it is the pancreas that fails not the patient Assess if greater
More informationInpatient Diabetes Care
Inpatient Diabetes Care Data from the National Diabetes Inpatient Audit suggest that the number of hospital inpatients with diabetes ranges from ~10% to over 30%. This does not mean that up to 1 in 3 inpatients
More informationTYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS
TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS The aim of the Diabetes level 2 service is to provide a high quality service for safe initiation and optimization of injectable therapy within GP networks.
More informationInsulin Therapies: An Educational Toolkit
University Hospitals of Leicester, Department of Diabetes and Leicester Diabetes Centre: Insulin Therapies: An Educational Toolkit This document is designed for use by those trained and competent in insulin
More informationClinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4
Clinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4 Page 1 of 27 Abbreviation Meaning PDSN DKA BG SC IV RCHT HDU PEWS Paediatric
More informationDiabetes Emergency Caesarean section or other unplanned surgery (GL822)
Diabetes Emergency Caesarean section or other unplanned surgery (GL822) i.e. insulin dependent diabetic having unplanned surgery e.g. a diabetic woman with pre-labour SROM prior to elective Caesarean section.
More informationGESTATIONAL DIABETES (DIET/INSULIN/ METFORMIN) CARE OF WOMEN IN BIRTHING SUITE
GESTATIONAL DIABETES (DIET/INSULIN/ METFORMIN) CARE OF WOMEN IN BIRTHING SUITE DEFINITION A disorder characterised by hyperglycaemia first recognised during pregnancy due to increased insulin resistance
More informationPlease inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.
Adult Diabetic Ketoacidosis Care Bundle (V1. Issued October 2014 Review October 2015) Improving patient care This pack includes: DKA Management Guideline Name: (Patient Addressograph) DOB: Hospital No:
More informationInjectable Therapies in Diabetes
Injectable Therapies in Diabetes Diabetes Specialist Nurse Joyce Robson Learning Outcomes Think about the place of injectible therapies in diabetes Think about when / why patients require insulin therapy
More informationOxford Kidney Unit. Preparing for your operation: information for people with chronic kidney disease
Oxford Kidney Unit Preparing for your operation: information for people with chronic kidney disease page 2 You have been given this booklet to help you prepare for a surgical procedure under general anaesthetic.
More informationInjectable Therapies in Diabetes
Injectable Therapies in Diabetes Diabetes Specialist Nurse Joyce Robson Learning Outcomes Think about the place of injectible therapies in diabetes Insulin therapy GLP1 antagonists Consider commonly used
More informationShort-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins
Recommended Insulin Products This guideline states the Gloucestershire Joint Formulary recommended, first choice insulin products. The intention is to support the choice of treatment for new patients,
More informationGuideline on Sick day rules for children and young people with diabetes on insulin
Guideline on Sick day rules for children and young people with diabetes on insulin META DATA Title: Guidelines on Sick day rules for children and young people with Diabetes taking insulin Version: 1.0
More informationPharmacological Glycaemic Control in Type 2 Diabetes
Pharmacological Glycaemic Control in Type 2 Diabetes Aim(s) and Objective(s) This guideline aims to offer advice on the pharmacological management for those who require measures beyond diet and exercise
More informationCountry Health SA Local Health Network. Version control and change history
Country Health SA Local Health Network Protocol (Clinical) Title: Diabetic Ketoacidosis Management in Adults with Type 1 Diabetes Protocol developed by: CHSALHN Diabetes Service Protocol Sponsor: CHSALHN,
More informationMaking Foot Surgery Safer for Patients with Diabetes
Making Foot Surgery Safer for Patients with Diabetes Building a New Trust Pathway Patient Safety Briefing The Newcastle Peri-operative Diabetes Pathway Launched 9 May 2016 Aims to join up peri-operative
More informationLeicestershire Diabetes Guidelines: Insulin Therapy
Endorsed by Leicestershire Medicines Strategy Group Leicestershire Diabetes Guidelines: Insulin Therapy These guidelines are designed for use by those trained and competent in insulin initiation and management
More informationManagement of Women with Type I Diabetes or Insulin Treated Type II Diabetes
Management of Women with Type I Diabetes or Insulin Treated Type II Diabetes Author: Women & Child Health Specialty: Labour Ward Forum Date Approved: March 2017 Approved by: W&CH Clinical Governance Committee
More informationMANAGEMENT OF TYPE 2 DIABETES
MANAGEMENT OF TYPE 2 DIABETES 3 Month trial of lifestyle changes. Refer to DESMOND structured education programme. Set glycaemic target HbA1c < 7.0% (53mmol/mol) or individualised If HbA1c > 53mmol/mol
More informationEnd of Life Diabetes Care
End of Life Diabetes Care Commissioned by Diabetes UK Supplementary Documents and Flowcharts Endorsed By: Diabetes Phases of End of Life and Medications A - Blue: All From Diagnosis Stable With Year Plus
More informationEndoscopy or colonoscopy guidelines
Endoscopy or colonoscopy guidelines for patients with diabetes The development and audit of local pilot guidelines for patients with diabetes undergoing an endoscopy or colonoscopy as an out-patient D
More informationGuidelines for the Management of Diabetic Ketoacidosis (DKA) in Adults Inpatient Diabetes Steering Group
Guidelines for the Management of Diabetic Ketoacidosis (DKA) in Adults Inpatient Diabetes Steering Group 1. Introduction 1.1 This document sets out the University Hospitals of Leicester (UHL) guidelines
More informationExecutive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)
Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) SETTING FOR STAFF PATIENTS Medical and nursing staff Children and young
More informationObjectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)
Acute Diabetes Emergencies Ross Buchan, DSN North Glasgow June 2017 Objectives Why is blood glucose important? Hypoglycaemia Hyperglycaemia Acute Diabetes Emergencies (DKA,HONK) Importance of Blood Glucose
More informationDrugs used in Diabetes. Dr Andrew Smith
Drugs used in Diabetes Dr Andrew Smith Plan Introduction Insulin Sensitising Drugs: Metformin Glitazones Insulin Secretagogues: Sulphonylureas Meglitinides Others: Acarbose Incretins Amylin Analogues Damaglifozin
More information667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY
667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY Contents Introduction... 1 Patient Education for People with Type 2 Diabetes... 2 Dietary Advice for People with Type 2 Diabetes...
More information9 Diabetes care. Back to contents
Back to contents Diabetes is a major risk factor for the development of peripheral vascular disease and 349/628 (55.6%) of the patients in this study had diabetes. Hospital inpatients with diabetes are
More informationSociety for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery
Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia
More informationDiabetes, Ketone testing in Type 1 Diabetes
CLINICAL GUIDELINE Diabetes, Ketone testing in Type 1 Diabetes A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised
More informationSTEP 3: Add or Substitute with one of
Prescribing of Hypoglycaemic Agents for Adult Patients with Type 2 Diabetes: Sunderland Refer to DESMOND Structured Education classes to promote Increased Physical Activity, Weight Loss and Calories Reduction
More informationInsulin Management. By Susan Henry Diabetes Specialist Nurse
Insulin Management By Susan Henry Diabetes Specialist Nurse The Discovery of Insulin - 1921 - Banting & Best University Of Toronto Discovered hormone insulin in pancreatic extract of dog - Marjorie the
More informationDeveloping a pathway of. and care planning for people with diabetes
Developing a pathway of preoperative assessment and care planning for people with diabetes Louise Hilton, Marie Digner Diabetes is a common endocrine condition affecting 1.4 million people in the UK, with
More informationObjectives. Why is blood glucose important? Hypoglycaemia. Hyperglycaemia. Acute Diabetes Emergencies (DKA,HONK)
Acute Diabetes Emergencies Ross Buchan, DSN North Glasgow September 2017 Objectives Why is blood glucose important? Hypoglycaemia Hyperglycaemia Acute Diabetes Emergencies (DKA,HONK) Importance of Blood
More informationInpatient Diabetes and Hyperglycaemia. Philip Dyer Heart of England NHS Foundation Trust Birmingham
Inpatient Diabetes and Hyperglycaemia Philip Dyer Heart of England NHS Foundation Trust Birmingham A Case of Inpatient Diabetes 22.09.15 Mrs DE Ketosis-prone T2DM on bd Humulin-I, Metformin and Linagliptin
More informationGuideline for antihyperglycaemic therapy in adults with type 2 diabetes
Guideline for antihyperglycaemic therapy in adults with type 2 diabetes Version Control Version Number Date Amendments made 1 January 2018 1.1 February 2018 Amended to reflect updated SPC advice for sitagliptin
More informationMANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY
MANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY Background Management is different in different groups of women with diabetes. Women with Type 1 Diabetes (previously
More informationInformation for all patients taking insulin who are admitted to hospital on day of surgery
Information for all patients taking insulin who are admitted to hospital on day of surgery Exceptional healthcare, personally delivered Introduction Many patients are now admitted to hospital on the day
More informationWhat the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin
Diabetes s Oral s - Pills These are some of the pills that are currently available in Canada to treat diabetes. Each medication has benefits and side effects you should be aware of. Your diabetes team
More informationYOU HAVE DIABETES. Angie O Connor Community Diabetes Nurse Specialist 25th September 2013
YOU HAVE DIABETES Angie O Connor Community Diabetes Nurse Specialist 25th September 2013 Predicated 2015 figures are already met 1 in 20 have diabetes:1in8 over 60years old Definite Diagnosis is key Early
More informationDiabetes and Pregnancy
Diabetes and Pregnancy Dr Warren Gillibrand Deputy Director of Postgraduate Education Department of Nursing & Midwifery Department of AHP and Sports Science w.p.gillibrand@hud.ac.uk Aims of the session
More informationDiabetes Update: Keeping patients safe. Victoria Ruszala MFRPSII North Bristol NHS Trust
Diabetes Update: Keeping patients safe Victoria Ruszala MFRPSII North Bristol NHS Trust Declaration of Interests I have received funding from the following companies for providing education sessions, attending
More informationDiabetes Labour guideline (GL820)
Diabetes Labour guideline (GL820) Approval Approval Group Job Title, Chair of Committee Date Maternity & Childrens Services Mr Mark Selinger, Consultant 6 th June 2014 Clinical Governance Committee Obstetrician
More informationGLP-1 Receptor Agonists and SGLT-2 Inhibitors. Debbie Hicks
GLP-1 Receptor Agonists and SGLT-2 Inhibitors Debbie Hicks Prescribing and Adverse Event reporting information is available at this meeting from the AstraZeneca representative The views expressed by the
More informationInitiating Injectables in Type 2 Diabetes. Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital
Initiating Injectables in Type 2 Diabetes Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital Increasing levels in delivery of diabetes care Complex Care support 3 3.1 People with diabetes
More informationTHIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN
Worcestershire Trusts Please attach patient sticker here or record: GP Name: Consultant:. Ward: THIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN This Care Pathway
More informationPHARMACOLOGY AND PHARMACOKINETICS
DRUG GUIDELINE Insulin, human neutral (Actrapid ) Intravenous Infusion for SCOPE (Area): FOR USE IN: Critical Care Unit, Emergency Department and Operating Suite EXCLUSIONS: Paediatrics (seek Paediatrician
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Proposed Health Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Proposed Health Technology Appraisal Dapagliflozin in combination therapy for the Final scope Remit/appraisal objective To appraise the clinical and
More informationVolume 2; Number 14 September 2008 NICE CLINICAL GUIDELINE 66: TYPE 2 DIABETES THE MANAGEMENT OF TYPE 2 DIABETES (MAY 2008)
Volume 2; Number 14 September 2008 NICE CLINICAL GUIDELINE 66: TYPE 2 DIABETES THE MANAGEMENT OF TYPE 2 DIABETES (MAY 2008) The purpose of this special edition of the PACE Bulletin is to summarize the
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal. Canagliflozin in combination therapy for treating type 2 diabetes
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Single Technology Appraisal Canagliflozin in combination therapy for Final scope Remit/appraisal objective To appraise the clinical and cost effectiveness
More informationArrange 3 Monthly Review Re-enforce LIFESTYLE advice and check DRUG COMPLIANCE at each visit Target HbA1c < 53mmol/mol
Prescribing of Hypoglycaemic Agents for Adult Patients with Type 2 Diabetes: Sunderland Refer to DESMOND Structured Education classes to promote Increased Physical Activity, Weight Loss and Calories Reduction
More informationA I Page 1 of 10. SIMPSON CENTRE FOR REPRODUCTIVE HEALTH ROYAL INFIRMARY of EDINBURGH. Clinical Protocol
SIMPSON CENTRE FOR REPRODUCTIVE HEALTH ROYAL INFIRMARY of EDINBURGH Clinical Protocol DIABETES IN PREGNANCY Diabetes; Management of GlycaemicControl in labour and in the antenatal period. Document Information
More informationDIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address:
1 DIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address: 2 Learning Outcomes All nurses, regardless of practice setting, are required to work collaboratively with the person
More informationInpatient Diabetes and Hyperglycaemia. Philip Dyer Heart of England NHS Foundation Trust Birmingham
Inpatient Diabetes and Hyperglycaemia Philip Dyer Heart of England NHS Foundation Trust Birmingham Outline of the Talk Definitions and the burden The impact and the cost A case The effects of hyperglycaemia
More informationAneurin Bevan University Health Board Diabetes in Pregnancy: Care Pathway for Management of Diabetes in Pregnancy
Aneurin Bevan University Health Board Diabetes in Pregnancy: Care Pathway for Management of Diabetes in Pregnancy N.B. Staff should be discouraged from printing this document. This is to avoid the risk
More informationCOMPLIANCE WITH THIS DOCUMENT IS MANDATORY
COVER SHEET `NAME OF DOCUMENT TYPE OF DOCUMENT at Shoalhaven Hospital Group Critical Care Procedure DOCUMENT NUMBER DATE OF PUBLICATION February 2018 RISK RATING Medium REVIEW DATE February 2021 FORMER
More informationMr Rab Burtun. Dr David Kim. 8:30-10:30 WS #2: Diabetes Basic 11:00-13:00 WS #9: Diabetes Basic (Repeated)
Dr David Kim Endocrinologist and General Physician Waitemata DHB and Apollo Specialist Clinic Albany Auckland Mr Rab Burtun Diabetes Nurse Specialist Waitemata DHB Waitakere Hospital Auckland 8:30-10:30
More informationType 2 diabetes in adults: controlling your blood glucose by taking a second medicine what are your options?
Patient decision aid Type 2 diabetes in adults: controlling your blood glucose by taking a second medicine what are your options? nice.org.uk/guidance/ng28 Published: December 2015 About this decision
More informationDiabetes and steroids: Storm conditions
Article Diabetes and steroids: Storm conditions June James Citation: James J (2016) Diabetes and steroids: Storm conditions. Journal of Diabetes Nursing 20: 128 33 Article points 1. Steroids are often
More informationGUIDELINES FOR THE TREATMENT OF DIABETIC KETOACIDOSIS (to be used in conjunction with DKA prescription and monitoring chart)
GUIDELINES FOR THE TREATMENT OF DIABETIC KETOACIDOSIS (to be used in conjunction with DKA prescription and monitoring chart) This guidance does not override the individual responsibility of health professionals
More informationEFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY
Specialist details Patient identifier Name Tel: EFFECTIVE SHARE CARE AGREEMENT FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY The aim of Effective Shared Care Guidelines
More informationBeing too sweet to siphon honey
Being too sweet to siphon honey Jay van der Westhuizen Auckland City Hospital, ew Zealand Guidelines for Peri-operative management of the Adult Diabetic patient. Scope of the problem Diabetes is a growing
More informationDiabetes medication pharmacology
BJA Education, 17 (6): 198 207 (2017) Matrix reference 1A02, 2A03, 3A06 doi: 10.1093/bjaed/mkw075 Advance Access Publication Date: 22 February 2017 Diabetes medication pharmacology Daniel J Stubbs BA BMBCh
More informationObjectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors
No disclosure Objectives Recognize all available medical treatment options for diabetes Individualize treatment and glycemic target based on patient factors Should be able to switch to more affordable
More informationFrailty and Type 2 Diabetes Guidelines for clinicians
H.G. WELLS PROJECT Frailty and Type 2 Diabetes Guidelines for clinicians Victoria Ruszala victoria.ruszala@nhs.net H.G. Wells Project team Dugal T, Partington E. Kernow CCG Diabetes and Frailty Guideline
More informationCase Study: Competitive exercise
Case Study: Competitive exercise 32 year-old cyclist Type 1 diabetes since age 15 Last HbA1 54 No complications and hypo aware On Humalog 8/8/8 and Levemir 15 Complains about significant hypoglycaemia
More informationManaging diabetes if you are having a colonoscopy
Managing diabetes if you are having a colonoscopy Diabetes and Endocrinology Patient Information Leaflet Introduction This leaflet provides advice and instructions to people with diabetes who are going
More informationsitagliptin, 25mg, 50mg and 100mg film-coated tablets (Januvia ) SMC No. (1083/15) Merck Sharp and Dohme UK Ltd
sitagliptin, 25mg, 50mg and 100mg film-coated tablets (Januvia ) SMC No. (1083/15) Merck Sharp and Dohme UK Ltd 07 August 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the
More information